You are required to be logged in to access the full website
Click here if you have forgotten your username or password
16 May 2025 - Biopharmaceutical company InnoCare Pharma (HKEX:09969) (SSE:688428) reported on Friday that the first patient has been dosed in a Phase II/III clinical trial of Soficitinib (ICP-332) for the treatment of non-segmental vitiligo in China....
16 May 2025 - Belgian biopharmaceutical company Oxurion NV (Euronext Brussels:OXUR) announced on Friday that it has signed a binding agreement to acquire 72% of French biometrics specialist Axiodis CRO through its French subsidiary, Oxurion France.Un...
16 May 2025 - Rznomics Inc, a South Korean biopharmaceutical company specialising in RNA-based therapeutics, announced on Thursday that it has entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company (...
16 May 2025 - Clinical-stage biotechnology company SparX Biopharmaceutical Corp announced on Thursday that it has entered into a research agreement with Mitsubishi Tanabe Pharma America Inc (MTPA).The collaboration aims to advance an antibody-drug co...
16 May 2025 - Pharmaceutical company Endo Inc (OTCQX: NDOI) announced Thursday the launch of ADRENALIN (epinephrine in 0.9% sodium chloride injection) 8 mg/250 mL premixed bag, and will begin distribution from the week of 19 May 2025.ADRENALIN is the...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe